Enlivex Therapeutics Ltd. buy Liberte
Start price
03.10.20
/
50%
€11.30
Target price
04.11.21
-
Performance (%)
-43.36%
End price
20.07.21
€6.40
Summary
This prediction ended on 20.07.21 with a price of €6.40. Massive losses of -43.36% were the result for the BUY prediction by Liberte. Liberte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Enlivex Therapeutics Ltd. | -3.008% | -3.008% | -48.400% | -83.671% |
| iShares Core DAX® | -0.268% | 5.471% | 14.271% | 19.027% |
| iShares Nasdaq 100 | 1.854% | 7.851% | 35.426% | 58.415% |
| iShares Nikkei 225® | 0.284% | 1.729% | 9.943% | 7.045% |
| iShares S&P 500 | 1.178% | 5.269% | 27.989% | 49.400% |
According to Liberte what are the pros and cons of Enlivex Therapeutics Ltd. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Liberte for this prediction
In the thread Enlivex Therapeutics Ltd. diskutieren
Buy Bio Blast Pharma Ltd